Egypt's interior ministry takes legal action against 5,226 drivers, 483 shops for violating COVID-19 preventive measures    UK cuts foreign aid spending commitment, causing outcry    Pioneers Holding's extraordinary meeting agrees to split into 3 firms    5th Aqarmap Online Expo 2020 start, 15 real estate developers participate    Sisi calls on citizens to closely observe COVID-19 preventive measures    WHO says cases drop, deaths rise in past week    Azerbaijani troops enter further territory ceded by Armenia    NBE: Exchange rates of key global currencies rates Wednesday 25-11-2020 vs. Egyptian pound    UAE halts new visas to citizens of 13 states: Document    Tuchel defends injury-ravaged PSG after lacklustre win over Leipzig    EgyptAir to begin operating weekly flight between Hurghada, Budapest on Saturdays    Barcelona benefited from fresh legs in win over Dynamo, says Koeman    EU says Ethiopia fighting destabilising region, urges ceasefire    UAE's ADGM to sign MOU with Israel's securities authority on fintech    Youthful Barca take care of Dynamo to seal knockout place    Akhenaten performance at the Cairo Opera House is a must go    An advisory chamber    GERD: A point of order?    Leapfrogging the transport network    Golden opportunities    The Egyptian Oedipus    Cairo International Book Fair suspended for five months over coronavirus concerns    AstraZeneca novel COVID-19 vaccine can be 90% effective, results show    Polling stations open at home for 1st stage of Egyptian parliamentary run-offs    Egypt confirms 358 new coronavirus cases, 14 deaths on Saturday    US will reduce number of its troop in Iraq, Afghanistan    Asia forms world's biggest trade bloc, a China-backed group excluding U.S    Egypt unveils largest archaeological discovery in 2020 with over 100 intact sarcophagi    Palestinians mourn the loss their longtime spokesman, Saeb Erekat    Trump says won't blame Egypt for being ‘upset' over GERD dispute with Ethiopia    1st stage of Egypt's parliamentary elections kicks off on Saturday    Global Finance: Egypt's Tarek Amer among the world's top 20 central bank governors    Legend footballer Lionel Messi says he is forced to stay with Barcelona    Egypt, Ethiopia, Sudan to resume Nile dam talks today    Iraqi conglomerate eyes developing land that housed Mubarak-era ruling party HQ    Legend Messi officially wants to leave Barcelona, hands transfer request    The Facebook Preacher's Search for Fame, and Egypt's Economy    Egypt calls on UNSC to address oil spill risks off Yemen coast    Egypt economically strong in face of COVID-19, reforms ongoing: International Cooperation Minister    Arafa Holding reports $144,000 COVID-19-related losses in April    Egypt's efforts in Libya to activate free will of Libyan people: Al-Sisi    Hyksos campaigns were internal takeover, not foreign invaders: study    COVID-19 affects Egypt sporting clubs    COVID-19 will soon turn to seasonal like swine flu: Presidential Health Advisor    ‘Egypt's Support' coalition convenes to discuss its Senate election list    Robbery attempt leads to discovery of Ptolemaic monuments in Qena    Flouting international guidance, Ethiopia unilaterally starts filling its Nile dam    Zaha speaks out after online racial abuse    







Thank you for reporting!
This image will be automatically disabled when it gets reported by several people.





Britain nears $625 mln Sanofi/GSK COVID-19 vaccine deal -report
Published in Ahram Online on 05 - 07 - 2020

Britain is close to a 500 million pound ($624 million) supply deal with Sanofi and GlaxoSmithKline for 60 million doses of a potential COVID-19 vaccine, the Sunday Times reported.
Clinical trials are due to start in September and Sanofi has said it expects to get approval by the first half of next year, sooner than previously anticipated.
More than 100 vaccines are being developed and tested around the world to stop the COVID-19 pandemic and governments are racing to secure supplies of vaccines even before their efficacy is proven.
A supply agreement with Sanofi and GSK would be Britain's second such deal, after it said it would buy 100 million doses of the Oxford-AstraZeneca vaccine.
Sanofi was not immediately available to comment, while a spokesman for GSK declined to comment. Both have both said they are prioritising quality over speed in developing a vaccine.
"The Government's Vaccines Task Force is actively engaging with a wide range of companies both in the UK and abroad to negotiate access to vaccines," a spokeswoman for Britain's business ministry, said, without confirming if Sanofi or GSK were among them.
The Sunday Times report said that Britain was considering taking an option to buy the vaccine should it work in human trials, and would see the amount paid in stages.
Sanofi is working on two possible COVID-19 vaccines, one of which uses an adjuvant made by GSK to potentially boost its efficacy, and has said it has capacity to produce up to 1 billion doses a year.
Its timeline for clinical trials is behind the likes of Moderna Inc, the University of Oxford in collaboration with AstraZeneca Plc, and an alliance of BioNTech and Pfizer Inc, whose projects all grabbed headlines by moving to human trials as early as March.
Sanofi has received financial backing from the United States and caused a stir in its home base of France after its British CEO Paul Hudson signalled that Europe was being too slow in supporting work on a vaccine, hinting U.S. patients might get any vaccine it develops first.
The EU is also seeking a deal with Sanofi, and has invited Britain to join its efforts to buy vaccines for the bloc. ($1 = 0.8011 pounds)


Clic here to read the story from its source.